CPA6 Gene Epilepsy familial temporal lobe type 5 Genetic Test
At DNA Labs UAE, we offer the CPA6 Gene Epilepsy familial temporal lobe type 5 Genetic Test. This test is designed to identify mutations in the CPA6 gene that are associated with familial temporal lobe epilepsy type 5 (FTLE5), a rare form of epilepsy characterized by seizures originating from the temporal lobe of the brain.
Test Components and Price
The price of the CPA6 Gene Epilepsy familial temporal lobe type 5 Genetic Test is 4400.0 AED. The test requires a sample condition of either blood, extracted DNA, or one drop of blood on an FTA Card. The report delivery time is 3 to 4 weeks, and the method used is NGS Technology.
Test Type and Doctor
The CPA6 Gene Epilepsy familial temporal lobe type 5 Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.
Test Department and Pre Test Information
The test is conducted in the Genetics department. Before undergoing the CPA6 Gene Epilepsy familial temporal lobe type 5 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected with CPA6 Gene Epilepsy, familial temporal lobe type 5.
Test Details
The CPA6 gene provides instructions for making an enzyme called carboxypeptidase A6, which plays a role in the breakdown of neuropeptides in the brain. Mutations in the CPA6 gene can disrupt the normal function of this enzyme, leading to an accumulation of neuropeptides. This accumulation can cause abnormal electrical activity in the brain, triggering seizures associated with FTLE5.
NGS genetic testing is used to identify mutations in the CPA6 gene associated with FTLE5. This type of testing involves sequencing the DNA of an individual to identify any changes or variations in the genetic code that may be responsible for the disorder. NGS testing is a valuable tool for diagnosing and managing FTLE5, as well as for identifying carriers of the mutation who may be at risk of passing the disorder on to their children.
| Test Name | CPA6 Gene Epilepsy familial temporal lobe type 5 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CPA6 Gene Epilepsy, familial temporal lobe type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CPA6 Gene Epilepsy, familial temporal lobe type 5 |
| Test Details | The CPA6 gene is associated with familial temporal lobe epilepsy type 5 (FTLE5), which is a rare form of epilepsy characterized by seizures originating from the temporal lobe of the brain. The CPA6 gene provides instructions for making an enzyme called carboxypeptidase A6, which is involved in the breakdown of neuropeptides in the brain. Mutations in the CPA6 gene have been shown to disrupt the normal function of this enzyme, leading to an accumulation of neuropeptides that can cause abnormal electrical activity in the brain and trigger seizures. NGS genetic testing can be used to identify mutations in the CPA6 gene that are associated with FTLE5. This type of testing involves sequencing the DNA of an individual to identify any changes or variations in the genetic code that may be responsible for the disorder. NGS testing can be a valuable tool for diagnosing and managing FTLE5, as well as for identifying carriers of the mutation who may be at risk of passing the disorder on to their children. |
